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Abstract
Background: Severe leptospirosis occurs mainly in a tropical environment and includes icterus, acute renal failure
and hemorrhages. These bleedings, which are mainly a consequence of acute homeostatic disturbances, can also
reveal simultaneous diseases. Coinfections with other tropical diseases have been previously reported during
leptospirosis. To our knowledge, invasive amebiasis, which can induce gastrointestinal bleedings, has never been
described in the course of severe leptospirosis.
Case presentation: In this report, we describe a case of a 60 year-old man living in Reunion Island (Indian Ocean,
France) admitted to our intensive care unit for severe Leptospira interrogans serovar icterohaemorrhagiae infection
with neurological, renal, liver and hematological involvement. Two lower gastrointestinal bleedings occurred 7 and
15 days after admission. The first episode was promoted by hemostatic disturbances while the second bleeding
occurred during low-dose heparin therapy. Colonoscopy revealed a pseudo-tumoral inflammatory mass of the
recto-sigmoid junction. Histological examination found trophozoites inside mucinous exudate suggestive of
Entamoeba histolytica. Amoebic serology was strongly positive whereas careful detection of cysts or trophozoites
on saline-wet mount was negative in three consecutive samples of stools. Amoxicillin followed by metronidazole
therapy, combined with supportive care, led to an improvement in the clinical and biological patient’s condition
and endoscopic appearances.
Conclusion: Clinicians should be aware that gastrointestinal bleeding during severe leptospirosis could not solely
be the consequences of hemostatic disturbances. Careful endoscopic evaluation that may reveal curable
coinfections should also be considered.
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Background
Leptospirosis is a worldwide zoonosis caused by patho-
genic Leptospira species which occurs predominantly in
warm and humid climates [1]. Direct or indirect contact
with urine of infected rodents or other animals can induce
human leptospirosis whose clinical spectrum can substan-
tially vary from one patient to another [2]. Most infections
are mild, characterised by sudden fever (97%), chills (78%),
headache (98%), myalgia with rhabdomyolysis (79%),
arthralgia (78%), gastrointestinal symptoms (35%), cough
(20%) and rash (7%) that can mimic many other infections
[3]. Aseptic meningitis has also been reported in up to
one-quarter of cases [4]. Weil’s disease, including jaundice,
acute renal failure and hemorrhage represents the most
severe form of the illness [5], with mortality rates ranging
from 5-15%. Pulmonary hemorrhage (occasionally compli-
cated by adult respiratory distress syndrome), myocarditis
and autoimmune-associated anterior uveitis [6] are also
classical clinical features reported in severe leptospirosis
cases.
Leptospirosis can also induce hemostasis disorders [7]
such as thrombocytopenia (reported in 50-80% of patients),
disseminated intravascular coagulation and more scarcely
reported, haemolytic uraemic syndrome and thrombotic
thrombocytopenic purpura. Endothelial dysfunction seems
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to play a crucial role in the loss of hemostasis during se-
vere leptospirosis [7]. Even if their pathophysiology is
not fully understood, hemorrhagic complications are re-
ported to affect 20-60% of patients suffering from severe
leptospirosis, with an incidence of less than 10% of
gastrointestinal bleeding [8,9]. One recent prospective
study found a high incidence (46%) of mild skin and
mucosal bleeding whereas, urinary or gastrointestinal
tract bleeding affected 13% of patients. A positive asso-
ciation between thrombocytopenia, increased pro-
thrombin time and severe bleeding was also reported.
Disseminated intravascular coagulation (DIC), which
was not per se associated with bleeding or mortality,
was found in 22% of patients [9].
Bleeding may affect leptospirosis prognosis especially
during intra-alveolar events [10]. In our experience from
Reunion Island (Indian Ocean, France), gastrointestinal
hemorrhages were also reported to be a common cause
of death during severe leptospirosis, especially in cases
of concomitant acute renal failure [4].
We report here the case of a severe lower intestinal
bleeding revealing ameboma during the course of Weil’s
disease.
Case presentation
A 60 year-old male smoker was admitted in our teaching
hospital for fever, intense asthenia, diffuse pain, myalgia,
headache, oliguria and jaundice of one week’s duration.
This patient was living in a rural area of Reunion Island
and was working daily barefoot in sugar cane fields. At
physical examination, cutaneous icterus and acute confu-
sion (without neurological focal signs nor clinical evidence
of meningitis) were noted. No hemorrhagic signs were re-
ported at admission. Biological tests revealed severe acute
renal failure (serum creatinine level = 1022 μmol/L) with
hyponatremia at 126 mmol/l, thrombocytopenia (43000/
mm3), leucocytosis (19600/mm3), mild cytolysis (alanine
aminotransferase = 213 IU/L) and severe jaundice (serum
bilirubin > 500 μmol/L). Slight rhabdomyolysis was also
noticed (creatin phosphokinase = 4475 IU/l). Prothrombin
ratio (PT) was in the normal range (70%) whereas acti-
vated partial thromboplastin time (APTT) was prolonged
(59 s, normal range: 30–41 s). Fibrinogen level was high
(8.9 g/l, normal range: 2–4 g/l). Lactate dehydrogenase
and haptoglobin blood levels were normal; no schistocytes
were seen on peripheral blood film. Cerebrospinal fluid
(CSF) analysis showed evidence of meningoencephalitis
(white blood cells = 20/mm3, protein level = 2.5 g/L).
Chest radiography was normal. Ultrasonography of liver
and kidneys was unremarkable. Three hemocultures per-
formed during fever peaks were negative. Severe lepto-
spirosis with muscular, neurological, liver, renal and
hematological involvement was suspected and quickly
confirmed by positive blood and urine PCR. Leptospirosis
serology (ELISA) was positive, concomitantly with IgM
against Leptospira interrogans serovar icterohaemorrha-
giae strain Verdun (titer = 1/800). Leptospirosis polymer-
ase chain reaction (PCR) in CSF was negative. Hepatitis
A, B, C and E, human immunodeficiency virus (HIV) and
dengue serologies were negative whereas chikungunya ser-
ology was positive for IgG without IgM indicating a past
infection (blood chikungunya PCR was negative). Rickett-
sia conorii, rickettsia typhi and coxiella burnetii serologies
were also negative.
Given the initial severity, the patient was monitored in
the Intensive Care Unit where neurological worsening
lead to tracheal intubation and mechanical ventilation
for 7 days. Parenteral amoxicillin (1 g t.i.d.) was adminis-
tered for 10 days. Acute renal failure was treated with
continuous veno-venous hemofiltration during 11 days,
followed by 3 additional conventional hemodialysis ses-
sions (Figure 1). Of note, a first episode of intestinal
bleeding requiring the first red blood cell transfusion
was reported on day 7. This bleeding complication un-
fortunately was unexplored. Because of reduced mobil-
ity, a persistent inflammatory state and the presence of a
central dialysis catheter in the right femoral vein, low-
dose prophylactic subcutaneous unfractionated heparin
sodium (2500 units bid) was used between day 9 and
day 14. Leptospirosis was considered to be effectively
treated: recovery of renal function occurred after 21 days
in hospital with a serum creatinine level slowly and con-
stantly decreased to 329 μmol/l upon discharge. A slow
improvement of serum liver profile was also observed
(serum bilirubin at discharge = 44 μmol/L).
At day 15 (Figure 1), while thrombocytopenia had
been completely resolved (259000/mm3), a second large
lower gastrointestinal bleed with acute anemia was no-
ticed (hemoglobin = 7 g/dL) requiring a red blood cell
transfusion of 7 units. Standard hemostasis tests were nor-
mal. Upper gastrointestinal endoscopy was normal whereas
colonoscopy revealed rectitis with pseudo-tumoral appear-
ance of the recto-sigmoid junction (Figure 2A). Patho-
logical examination of rectal biopsies found no neoplastic
change, but rather a nonspecific mucosal thickening, acute
ulceration together with blue oval structures inside mucin-
ous exudate containing eccentric nuclei, suggesting the
presence of Entamoeba histolytica trophozoites (Figure 3).
Attempted careful detection of cysts or trophozoites on
saline-wet mount was negative in three consecutive sam-
ples of stools. However, indirect hemagglutination amebia-
sis serology was strongly positive (titer = 1/2048) suggestive
of invasive pseudo-tumoral colitis i.e. an ameboma. Oral
metronidazole (500 t.i.d) was introduced for 10 days
followed by luminal decontamination with tibroquinol-
tiliquinol association (Intetrix®, the only luminal amebicide
available in France). Repeated liver ultrasonography did
not find evidence of an amebic abscess. Of note, blood
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cytomegalovirus (CMV) PCR was found positive (3.03 log)
with positive IgG serology, without IgM. CMV immuno-
staining of colic biopsies did not reveal evidence of viral
colitis. This mild blood CMV reactivation was considered
as an asymptomatic reactivation and no antiviral therapy
was started.
One month after discharge, a repeat endoscopy re-
vealed slight and healing ulceration of the middle rectum
(Figure 2B). No new gastrointestinal bleeding was re-
ported. The serum creatinine level was still decreasing to
156 μmol/L. Three months after discharge, the patient’s
overall condition significantly improved and he felt able to
work again. Physical examination was unremarkable.
Serum creatinine was 111 μmol/L and amoebic serology
titer was also decreasing (1/640). Serum liver enzymes
were normal. Blood PCR for leptospirosis and CMV be-
came negative.
Discussion
Leptospirosis is a widespread zoonosis of global distribu-
tion but is more common in tropical areas where condi-
tions for its transmission are particularly favourable.
Although considered as an occupational disease, a higher
proportion of cases related to recreational water based
activity have been reported [3]. A mean of 55 annual
confirmed cases were reported between 1998 and 2008
in Reunion Island with a high rate of infections between
February and May, positively correlated with total rain-
fall, average temperature and global solar radiation [11].
Leptospira are highly motile aerobic spirochetes that can
be directly transmitted via contact with infected tissues
or contaminated urine, or indirectly by contact with
water or soil contaminated with the urine of mammalian
reservoirs. As is likely in our report, many infections can
result from walking barefoot in damp conditions or
Figure 2 Endoscopic findings. A: First colonoscopy showing rectitis and a pseudo-tumoral nodules of recto-sigmoid junction (black arrow).
B: Second colonoscopy, one month after the effective treatment of invasive amebiasis, revealed a small and healing ulceration of the middle rectum.
Figure 1 Evolution of clinical and biological patient’s condition. Platelet counts (blue line) and hemoglobin level (red line) during course of
leptospirosis and amebiasis together with clinical gastrointestinal bleeding periods, red blood cell transfusions, antibiotic and renal replacement
therapies. Red numbers above the arrows refer to the numbers of Units of packed cells transfused.
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gardening with bare hands [12]. Differential diagnosis of
leptospirosis in Reunion Island should include chikun-
gunya disease, whose incidence during the 2005–2006
outbreak was almost 40% [13], and dengue fever, whose
overall seroprevalence in a recent blood donors survey
was 3.5% [14]. Well-known independent risk factors for
severe forms of leptospirosis (such as current cigarette
smoking, delay >2 days between the onset of symptoms
and the initiation of antibiotherapy or Leptospira interro-
gans serogroup icterohaemorrhagiae as the infecting
strain [15]) were all found in our reported case.
In severe forms, leptospirosis can be complicated by
hemorrhages (typically ranging from minor conjunctival
suffusions to more serious pulmonary involvement with
hemoptysis) whose pathogenesis remains not fully eluci-
dated. A review focusing on this issue concluded that the
bleeding tendency results from an imbalance in the
hemostatic equilibrium that may lead to DIC [7], which
concerned nearly half of confirmed cases in Thailand [8].
In our report, initial laboratory tests allowed us to rule out
DIC; PT was normal and only APTT was increased, a
classical finding not reported to be associated with bleed-
ing [8]. However, thrombocytopenia < 100000/mm3 at ad-
mission could have triggered the first intestinal bleed that
unfortunately was not investigated by endoscopies. In re-
cent papers, prevalence of thrombocytopenia < 100000/
mm3 during the initial phase of leptospirosis was signifi-
cantly higher among patients with than among those with-
out bleeding [8,9]. Mechanisms of thrombocytopenia
during leptospirosis are not fully understood: direct bone
marrow toxicity of organism [16], platelet consumption
due to DIC, immune-mediated causes [17] and platelet-
activating aggregates related to direct endothelial damage
of Leptospira (reviewed in [10]) were proposed. Throm-
botic microangiopathy has been rarely reported during
leptospirosis [18,19]. Unfortunately, bone marrow aspir-
ation was not realized during the initial course of our pa-
tient’s history but peripheral thrombotic microangiopathy
was ruled out (no evidence of hemolysis and no blood
schistocytes upon admission). Finally, acute renal failure,
which has been independently associated with mortality
during leptospirosis [20], could have also contributed to
these hemorrhages. Intrinsic platelet abnormalities, altered
platelet-vessel wall interaction, dialysis and need of anti-
coagulant therapies are suggested factors that could pro-
mote bleeding diathesis during advanced kidney diseases
[21]. In our report, we hypothesize that the second gastro-
intestinal bleed, occurring when platelet count was back
to normal, could have possibly been triggered by a degree
of prolonged uremic platelet dysfunction and by low-dose
unfractionated heparin (Figure 1). Within the context of a
recent unexplained gastrointestinal bleed and an acute in-
fection known to predispose to haemorrhage, the balance
between bleeding and thrombosis risk should be carefully
weighted before introducing prophylactic anticoagulant
therapy in critically ill patients [22].
During leptospirosis, coinfections with other tropical
diseases (dengue fever, HIV, hepatitis A and E, scrub ty-
phus, melioidosis and malaria [23-29]) have been previ-
ously reported but to our knowledge, our case represents
the first simultaneous association of leptospirosis and
amebiasis. Entamoeba histolytica is a protozoan parasite
whose ingestion of cysts from contaminated food can in-
duce amebiasis. Intestinal amebiasis has a worldwide dis-
tribution but disease is more frequently found in
developing countries where risk of fecal contamination is
high. In Reunion Island, only sporadic cases of amebiasis
have been described [30]. During 2012 and 2013, on 60
serological tests performed in our laboratory, only 5 were
positive for antiamebic antibodies (data non published).
Self-limiting asymptomatic infections constitute 90% of
cases whereas invasive colitis and amebic liver abscess
represent only 10% and <1% of cases respectively. Invasive
colitis results from excystation in the intestinal lumen pro-
ducing trophozoites that can penetrate the mucous layer
and epithelial cells [31]. It is well known that patients with
invasive amebiasis may rarely develop tumorous, exophy-
tic, solitary and inflammatory masses called “amebomas”
that can be up to 15 cm in diameter. In cases of amebo-
mas, stool examinations even if repeated are often nega-
tive whereas serological sensitivity is approximatively 70%
positive [32]. It has been suggested that amebomas can
Figure 3 Histological examination of rectal biopsy. The ulcerative lesion with nonspecific mucosal thickening together with blue oval structures
(black arrow) with eccentric nuclei was suggestive of Entamoeba histolytica trophozoites. A: hematoxylin-eosin, × 20. B: hematoxylin-eosin, × 40.
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occur in patients with long-standing, untreated or inad-
equately treated amebiasis [33]. In our case, we
hypothesize that asymptomatic ameboma was probably
present several weeks or months before admission and
that leptospirosis-induced hemostasis disturbances allowed
it to become symptomatic. Chronic clinical presentations
include alternating diarrhea and constipation, weight loss,
low-grade fever, cramping lower abdominal pain, palpable
mass and obstructions. It can be endoscopically indistin-
guishable from inflammatory bowel disease, diverticulitis,
pseudomembranous colitis or malignancy, especially in
cases of concomitant liver abscess that might mimic meta-
static colon cancer [34]. In most cases, after adapted drug
therapy of ameboma, repeated colonoscopies reveal no ab-
normality [34].
Conclusion
In conclusion, our report emphasises several key points that
could improve management of patients with severe lepto-
spirosis. Firstly, it highlights the importance of hemostasis
disturbances and the need of a careful daily screening of
bleeding consequences, especially during anticoagulation
periods. Secondly, our report illustrates that bleeding may
not only be the consequence of coagulation disorders dur-
ing leptospirosis, and should be rigorously explored as early
as possible since coincident diseases can be easily diagnosed
and cured. We would recommend that severe gastrointes-
tinal bleeding (defined by the need of transfusion support
or hemodynamic instability together with acute anaemia)
during leptospirosis should be promptly explored by oeso-
phagogastroduodenoscopy and/or colposcopy as it is rec-
ommended in the general population. Thirdly, even if
clinical features are sometimes unreliable to distinguish be-
tween them, two tropical infections can coexist in high-risk
patients. As in our report, acute infections such as lepto-
spirosis can unmask latent diseases such as amebomas.
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